Capital Investment Advisory Services, LLC Edwards Lifesciences Corp Transaction History

Capital Investment Advisory Services, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$102.91 - $122.75 $866,605 - $1.03 Million	-8,421 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$83.84 - $104.76 $706,016 - $882,183	8,421 New	8,421 $872,000
Q4 2019 Feb 04, 2020	SELL	$71.7 - $82.09 $30,042 - $34,395	-419 Closed	0 $0
Q3 2019 Oct 17, 2019	SELL	$61.55 - $75.43 $307 - $377	-5 Reduced 1.18%	419 $92,000
Q2 2019 Aug 08, 2019	SELL	$55.74 - $64.41 $1,727 - $1,996	-31 Reduced 6.81%	424 $82,000
Q1 2019 Apr 23, 2019	SELL	$47.89 - $64.05 $47,890 - $64,050	-1,000 Reduced 68.73%	455 $87,000
Q2 2018 Aug 01, 2018	SELL	$42.45 - $51.3 $2,122 - $2,565	-50 Reduced 3.32%	1,455 $212,000
Q1 2018 Apr 30, 2018	BUY	$37.19 - $47.45 $55,970 - $71,412	1,505 New	1,505 $210,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.